BioSpace News Archive

Can-Fite CEO to Present Namodenoson’s Clinical Trial Data as Expert Speaker at 5th Annual Antifibrotic Drug Development Summit

Exo Therapeutics, Inc. today announced the appointment of Dorothy Lou Bailey as Senior Vice President, Corporate Development and Strategy.

Verastem Oncology today announced the appointment of Michelle Robertson to its Board of Directors, effective November 15, 2021.

SciNeuro Pharmaceuticals and Mabylon AG today announced the establishment of a multi-program collaboration and license agreement.

Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH) today announced that it will report its third quarter 2021 financial results on Tuesday, November 2, 2021.

AVROBIO, Inc. today announced the appointment of Essra Ridha, M.D., MRCP, FFPM, as chief medical officer.

ContraFect Corporation today announces it will be presenting a poster on the activity of DLAs against common Gram-negative pathogens responsible for pulmonary infections in Cystic Fibrosis patients at the North American Cystic Fibrosis Conference, which will be held virtually from November 2-5, 2021.

Unicycive Therapeutics, Inc. today announced the appointment of Douglas Jermasek as Executive Vice President, Corporate Strategy.

Infinity Pharmaceuticals, Inc . will host a conference call on Tuesday, November 2 nd 2021, at 4:30pm ET to report its financial results for the third quarter of 2021.

Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the Credit Suisse 30th Annual Healthcare Conference on Tuesday, November 9, 2021.